Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Y Shaw

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Chronic Diseases in Canada|November 28, 2008
Population-based data sources for chronic disease surveillanceL M Lix, M S Yogendran, S Y Shaw, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Human erythrocyte glucose transporter: normal asymmetric orientation and function in liposomesC C Chen, T Kurokawa, S Y Shaw, et al.
The Journal of Biological Chemistry|November 5, 1993
Effect of heavy chain signal peptide mutations and NH2-terminal chain length on binding of anti-digoxin antibodiesJ Ping, J F Schildbach, S Y Shaw, et al.
Lab on a Chip|July 5, 2012
On-chip bioorthogonal chemistry enables immobilization of in situ modified nanoparticles and small molecules for label-free monitoring of protein binding and reaction kineticsC Tassa, M Liong, S Hilderbrand, et al.
Alimentary Pharmacology & Therapeutics|April 14, 2015
Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseasesA N Ananthakrishnan, A Cagan, T Cai, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1991
A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivoM S Runge, T Quertermous, P J Zavodny, et al.
Nature Structural Biology|July 1, 1997
Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28W J Metzler, J Bajorath, W Fenderson, et al.
Circulation|September 15, 1996
Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboonsM S Runge, L A Harker, C Bode, et al.
Circulation Research|May 12, 1998
Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokinesW S Lee, M K Jain, B M Arkonac, et al.
Protein Science : a Publication of the Protein Society|May 1, 1994
Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibodyJ F Schildbach, S Y Shaw, R E Bruccoleri, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Chronic Diseases in Canada|November 28, 2008
Population-based data sources for chronic disease surveillanceL M Lix, M S Yogendran, S Y Shaw, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Human erythrocyte glucose transporter: normal asymmetric orientation and function in liposomesC C Chen, T Kurokawa, S Y Shaw, et al.
The Journal of Biological Chemistry|November 5, 1993
Effect of heavy chain signal peptide mutations and NH2-terminal chain length on binding of anti-digoxin antibodiesJ Ping, J F Schildbach, S Y Shaw, et al.
Lab on a Chip|July 5, 2012
On-chip bioorthogonal chemistry enables immobilization of in situ modified nanoparticles and small molecules for label-free monitoring of protein binding and reaction kineticsC Tassa, M Liong, S Hilderbrand, et al.
Alimentary Pharmacology & Therapeutics|April 14, 2015
Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseasesA N Ananthakrishnan, A Cagan, T Cai, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1991
A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivoM S Runge, T Quertermous, P J Zavodny, et al.
Nature Structural Biology|July 1, 1997
Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28W J Metzler, J Bajorath, W Fenderson, et al.
Circulation|September 15, 1996
Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboonsM S Runge, L A Harker, C Bode, et al.
Circulation Research|May 12, 1998
Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokinesW S Lee, M K Jain, B M Arkonac, et al.
Protein Science : a Publication of the Protein Society|May 1, 1994
Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibodyJ F Schildbach, S Y Shaw, R E Bruccoleri, et al.
Pageof 3